Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology That May Benefit from Adjuvant Radiation
Publication
, Conference
Fecteau, RE; Liu, D; Barbieri, CE; Nagar, H
Published in: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020
Duke Scholars
Published In
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
EISSN
1879-355X
ISSN
0360-3016
Publication Date
2020
Volume
108
Issue
3
Start / End Page
S4 / S4
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fecteau, R. E., Liu, D., Barbieri, C. E., & Nagar, H. (2020). Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology That May Benefit from Adjuvant Radiation. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (Vol. 108, pp. S4–S4).
Fecteau, R. E., D. Liu, C. E. Barbieri, and H. Nagar. “Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology That May Benefit from Adjuvant Radiation.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108:S4–S4, 2020.
Fecteau RE, Liu D, Barbieri CE, Nagar H. Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology That May Benefit from Adjuvant Radiation. In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2020. p. S4–S4.
Fecteau, R. E., et al. “Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology That May Benefit from Adjuvant Radiation.” INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 108, no. 3, 2020, pp. S4–S4.
Fecteau RE, Liu D, Barbieri CE, Nagar H. Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology That May Benefit from Adjuvant Radiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2020. p. S4–S4.
Published In
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
EISSN
1879-355X
ISSN
0360-3016
Publication Date
2020
Volume
108
Issue
3
Start / End Page
S4 / S4
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences